Condition: Tricuspid Regurgitation · Sponsor: Micro Interventional Devices
The purpose of the study is to evaluate the safety and performance of the MIA Minimally Invasive Annuloplasty Device in patients with chronic functional tricuspid regurgitation.
This description comes directly from the study's public registry record.
Angie Swenson · aswenson@microinterventional.com
Always discuss trial participation with your own doctor first.
| Aarhus University Hospital | Aarhus, Denmark | Not Yet Recruiting |
| Semmelweis University, Heart and Vascular Center | Budapest, Hungary | Not Yet Recruiting |
| Centre of Cardiology, Pauls Stradins Clinical University Hospital | Riga, Latvia | Recruiting |
| Lithuanian University of Health Sciences | Kaunas, Lithuania | Recruiting |
| Vilnius University Hospital Santariskiu Klinikos | Vilnius, Lithuania | Recruiting |
| The Cardinal Stefan Wyszyński Institute of Cardiology | Warsaw, Poland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03692598